New Insights in Laboratory Medicine

New Insights in Laboratory Medicine

Monday, February 3, 2025 11:30 AM to 2:00 PM · 2 hr. 30 min. (Asia/Dubai)
Room Oman

Information

We are very grateful to the speakers from 5 countries for their abundant and excellent presentations. They will pass on and share their experiences in iron deficiency biological diagnosis, screening and diagnosis of primary aldosteronism, celiac disease in children, interference in immunoassays, laboratory management, etc. Let's share this feast of laboratory medicine!

Learning objectives

Knowing the main mechanisms and molecular actors of iron metabolism

Choosing the good biomarkers for iron deficiency biological diagnosis, knowing their strengths and limitations

Understand a pure practical report about how the lab was forced to transfer the test analysis renin, aldosterone and their ratio into different technologies

For early diagnostic screening, it's better to use both DGP along with TTG. This especially gets more important for children and IgA-deficient

Understand the interference in immunoassay

Learn the philosophy and experience of laboratory management, and learn how to develop effective multichannel communication with lab customers

This is an ATTEND IN PERSON session, taking place at Oman Room DWTC. If you have any questions about the session, please send an email to Customer Success Team.IMCustomerSuccess@informa.com

Location
Room Oman
Conference Track
Workshop
Snibe Co., Ltd.Z5.C30Shenzhen New Industries Biomedical Engineering Co., Ltd (briefed as Snibe) is a leading global in-vitro diagnostic biomedical enterprise that has been focusing on the Chemiluminescence immunoassay (CLIA) field for over 29 years, and has become the first CLIA manufacturer in China who got FDA cleared in 2017. Snibe offers customized diagnostic solutions to laboratories in more than 155 countries and regions. Over 30,000 units of Snibe's CLIA analyzers have been installed in hospitals and labs worldwide, including many top global chain labs. Over 29 years, Snibe has established 4 core R&D centers, including reagent, instrument, magnetic microbead, and reagent raw material, laying a solid foundation for developing the widest range of CLIA analyzers and test menus. Currently, Snibe's business segments cover various sections of clinical laboratory diagnosis, including CLIA, Biochemistry, Molecular Diagnostics, and Hemostasis, comprehensively meeting different diagnostic needs. Our Mission is "Creating value for human health through continuous innovation".

Log in